Start Time: 08:30 January 1, 0000 9:07 AM ET

InMode Ltd. (NASDAQ:INMD)
Q2 2024 Earnings Conference Call
August 01, 2024, 08:30 AM ET

Company Participants

Moshe Mizrahy - CEO
Michael Kreindel - Co-Founder and Chief Technology Officer
Yair Malca - CFO
Shakil Lakhani - President, North America
Eran Krieger - Medical Director and VP of Medical Affairs
Rafael Lickerman - Vice President, Finance
Miri Segal - CEO, MS-IR

Conference Call Participants

Danielle Antalffy - UBS
Caitlin Cronin - Canaccord Genuity
Jeff Johnson - Baird
Joseph Conway - Needham and Company

Operator

Good day, and welcome to InMode's Second Quarter 2024 Earnings Results Conference Call. All participants will be in listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note this event is being recorded.

I would now like to turn the conference over to Miri Segal, CEO of MS-IR. Please go ahead.

Miri Segal

Thank you, operator and everyone for joining us today. Welcome to InMode's conference call. Before we begin, I would like to remind our listeners that certain information provided on this call may contain forward-looking statements and the Safe Harbor statement outlined in today's earnings release also pertains to this call. If you have not received a copy of the release, please visit the Investor Relations section of the company's IR website.

Changes in business, competitive, technological, regulatory and other factors could cause actual results to differ materially from those expressed by the forward-looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of our forward-looking statements and assume no obligation to update them, except as required by law.

With that, I'd like to pass the call over to Moshe Mizrahi, InMode's CEO. Moshe, please go ahead.

Moshe Mizrahy

Thank you, Miri, and to everyone for joining us. With me today are Dr. Michael Kreindel, our Co-Founder and Chief Technology Officer; Yair Malca, our CFO; Shakil Lakhani, our President in North America; our Medical Director and VP of Medical Affairs, Dr. Eran Krieger; and Rafael Lickerman, our VP of Finance. Following our prepared remarks, we will all be available for question-and-answer.

I would like to highlight the development of the second quarter. As we previously mentioned in Q1, we launched our two new advanced platforms, IgniteRF and Optimus Max. We are happy to report that we have begun deliveries of both platforms and we believe we are on track to complete deliveries of pre-orders before the end of the year.